Ancora Heart
MaryAnne McNulty, ACRP-CP, possesses extensive experience in clinical research and quality assurance, currently serving as a Senior Clinical Research Associate at Ancora Heart, Inc. since March 2019. Prior experience includes roles as a Quality Assurance Specialist at Stanford University School of Medicine and Stanford Cancer Institute from June 2015 to March 2019, and as a Clinical Research Coordinator at Palo Alto Medical Foundation Research Institute from June 2014 to February 2015. MaryAnne has also held positions at Abbott Vascular, where responsibilities included Clinical Quality Associate and Clinical Trial Administrator from September 1999 to February 2014, and as a Clinical Research Coordinator at Fertility Physicians of Northern California from July 1986 to July 1996. Educational qualifications include an Associate's Degree in Health Records Technology and an Associate's Degree in Radiologic Technology from Gwynedd-Mercy College, along with a Bachelor's Degree in Health Services Administration from St. Mary's College of California.
Ancora Heart
Ancora Heart is a medical device company dedicated to providing new treatment options for people with heart failure (HF). The company’s proprietary AccuCinch® Ventricular Restoration System is the first completely percutaneous device designed to restore the enlarged left ventricle of the heart, thereby addressing the fundamental issue in the progression of systolic heart failure.